Browse > Article
http://dx.doi.org/10.5483/BMBRep.2014.47.9.212

PER3, a novel target of miR-103, plays a suppressive role in colorectal cancer in vitro  

Hong, Zhang (The Nurse Department of Organ Transplantation, Xiangya Hospital, Central South University)
Feng, Zhang (Xiangya School of Medicine, Central South University)
Sai, Zhang (Institute of Medical Sciences, Xiangya Hospital, Central South University)
Tao, Su (Institute of Medical Sciences, Xiangya Hospital, Central South University)
Publication Information
BMB Reports / v.47, no.9, 2014 , pp. 500-505 More about this Journal
Abstract
Colorectal cancer has become the third most common cancer and leads to high mortality worldwide. Although colorectal cancer has been studied widely, the underlying molecular mechanism remains unclear. PER3 is related to tumor differentiation and the progression of colorectal cancer. High expression of miR-103 is associated with poor prognosis in patients with colorectal cancer. However, the relationship between miR-103 and PER3 in CRC cells remains unclear. In this study, we found that PER3 was downregulated in CRC tissues and CRC cell lines, whereas miR-103 was upregulated in CRC cell lines. We also found that PER3 promoted CRC cells apoptosis. These results indicate that PER3 plays a suppressive role in CRC cells. Moreover, we found that PER3 was targeted, at least partially, by miR-103. Taken together, we provide evidence to characterize the role of PER3 in CRC, which may be a new therapeutic target for CRC.
Keywords
Circadian clock gene; Colorectal cancer; miR-103; Period3; Vitro;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Xu, Y., Zhao, F., Wang, Z., Song, Y., Luo, Y., Zhang, X., Jiang, L., Sun, Z., Miao, Z. and Xu, H. (2012) MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 31, 1398-1407.   DOI
2 Liu, M., Lang, N., Qiu, M., Xu, F., Li, Q., Tang, Q., Chen, J., Chen, X., Zhang, S., Liu, Z., Zhou, J., Zhu, Y., Deng, Y., Zheng, Y. and Bi, F. (2011) miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells. Int. J. Cancer. 128, 1269-1279.   DOI   ScienceOn
3 Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S. and Allgayer, H. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136.   DOI   ScienceOn
4 Weber, D. G., Johnen, G., Bryk, O., Jockel, K. H. and Bruning, T. (2012) Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma--a pilot study. PLoS One 7, e30221.   DOI
5 Niquet, J. and Wasterlain, C. G. (2004) Bim, Bad, and Bax: a deadly combination in epileptic seizures. J. Clin. Invest. 113, 960-962.   DOI   ScienceOn
6 Danial, N. N. and Korsmeyer, S. J. (2004) Cell death: critical control points. Cell 116, 205-219.   DOI   ScienceOn
7 Shapiro, G. I. (2006) Cyclin-dependent kinase pathways as targets for cancer treatment. J. Clin. Oncol. 24, 1770-1783.   DOI   ScienceOn
8 Xu, Y. (2008) Induction of genetic instability by gain-offunction p53 cancer mutants. Oncogene 27, 3501-3507.   DOI   ScienceOn
9 Vousden, K. H. and Lane, D. P. (2007) p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275-283.   DOI   ScienceOn
10 Calin, G. A. and Croce, C. M. (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866   DOI   ScienceOn
11 Yu, D., Zhou, H., Xun, Q., Xu, X., Ling, J. and Hu, Y. (2012) microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3. Oncol. Lett. 3, 1221-1226.   DOI
12 Annibali, D., Gioia, U., Savino, M., Laneve, P., Caffarelli, E. and Nasi, S. (2012) A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2. PLoS One 7, e40269.   DOI
13 Sato, F., Wu, Y., Bhawal, U. K., Liu, Y., Imaizumi, T., Morohashi, S., Kato, Y. and Kijima, H. (2011) PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cells. Eur. J. Cancer 47, 1747-1758.   DOI   ScienceOn
14 Chen, H. Y., Lin, Y. M., Chung, H. C., Lang, Y. D., Lin, C. J., Huang, J., Wang, W. C., Lin, F. M., Chen, Z., Huang, H. D., Shyy, J. Y., Liang, J. T. and Chen, R. H. (2012) miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res. 72, 3631-3641.   DOI   ScienceOn
15 Sahar, S. and Sassone-Corsi, P. (2009) Metabolism and cancer: the circadian clock connection. Nat. Rev. Cancer 9, 886-896.   DOI   ScienceOn
16 Zhu, Y., Stevens, R. G., Hoffman, A. E., Fitzgerald, L. M., Kwon, E. M., Ostrander, E. A., Davis, S., Zheng, T. and Stanford, J. L. (2009) Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res. 69, 9315-9322.   DOI   ScienceOn
17 Mazzoccoli, G., Panza, A., Valvano, M. R., Palumbo, O., Carella, M., Pazienza, V., Biscaglia, G., Tavano, F., Di Sebastiano, P., Andriulli, A. and Piepoli, A. (2011) Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients. Chronobiol. Int. 28, 841-851.   DOI   ScienceOn
18 Matsuo, T., Yamaguchi, S., Mitsui, S., Emi, A., Shimoda, F. and Okamura, H. (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302, 255-259.   DOI   ScienceOn
19 Gery, S. and Koeffler, H. P. (2007) The role of circadian regulation in cancer. Cold. Spring. Harb. Symp. Quant. Biol. 72, 459-464.   DOI   ScienceOn
20 Buhr, E. D. and Takahashi, J. S. (2013) Molecular components of the Mammalian circadian clock. Handb. Exp. Pharmacol. 217, 3-27.   DOI
21 Wang, X., Yan, D., Teng, M., Fan, J., Zhou, C., Li, D., Qiu, G., Sun, X., Li, T., Xing, T., Tang, H., Peng, X. and Peng, Z. (2012) Reduced expression of PER3 is associated with incidence and development of colon cancer. Ann. Surg. Oncol. 19, 3081-3088.   DOI   ScienceOn
22 Gaziel-Sovran, A., Segura, M. F., Di Micco, R., Collins, M. K., Hanniford, D., Vega-Saenz, D. M. E., Rakus, J. F., Dankert, J. F., Shang, S., Kerbel, R. S., Bhardwaj, N., Shao, Y., Darvishian, F., Zavadil, J., Erlebacher, A., Mahal, L. K., Osman, I. and Hernando, E. (2011) miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell. 20, 104-118.   DOI   ScienceOn